Published in Br J Pharmacol Chemother on February 01, 1968
Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature. Br J Pharmacol (1980) 1.86
Some quantitative uses of drug antagonists. Br J Pharmacol Chemother (1959) 41.90
The action of reserpine on the peripheral sympathetic system. J Physiol (1958) 4.27
'Cross-protection' method as a means of differentiating receptors. Nature (1962) 0.93
Adrenoceptive receptors in the duodenum, aorta and atria of the rabbit. J Pharm Pharmacol (1967) 0.92
A comparison of the vascular dopamine receptor with other dopamine receptors. Annu Rev Pharmacol Toxicol (1978) 1.41
Selective DA2 versus DA1 antagonist activity of domperidone in the periphery. Eur J Pharmacol (1983) 1.07
Excitatory action of sympathomimetic amines on 5-hydroxytryptamine receptors of gut. Br J Pharmacol (1969) 1.01
Peripheral pre- and post-synaptic dopamine receptors: are they different from dopamine receptors in the central nervous system? Commun Psychopharmacol (1979) 1.00
Adrenoceptive receptors in the duodenum, aorta and atria of the rabbit. J Pharm Pharmacol (1967) 0.92
Regional variation in the alpha-adrenergic receptors in the canine resistance vessels. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.92
Characteristics of the vascular dopamine receptor: comparison with other receptors. Fed Proc (1978) 0.91
2,3-Dihydroxy-9-amino-9,10-dihydrophenanthrene, a rigid congener of dopamine and isoapomorphine. J Med Chem (1978) 0.91
Absorption and excretion of 2,4-dichlorophenoxyacetic acid in man. Xenobiotica (1974) 0.90
A comparative study of dopamine and noradrenaline on the rabbit aorta. Can J Physiol Pharmacol (1969) 0.88
Separation of peripheral dopamine receptors by a selective DA1 antagonist, SCH 23390. Hypertension (1984) 0.86
Cardiovascular effects of (--)-cathinone in the anaesthetized dog: comparison with (+)-amphetamine. J Pharm Pharmacol (1982) 0.86
Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog. J Pharmacol Exp Ther (1987) 0.86
Alpha-adrenergic blocking action of propranolol. J Pharm Pharmacol (1967) 0.85
Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors. J Pharmacol Exp Ther (1980) 0.85
Relative activities of SCH 23390 and its analogs in three tests for D1/DA1 dopamine receptor antagonism. Eur J Pharmacol (1986) 0.85
Dopamine agonist properties of N-alkyl-4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinolines. J Med Chem (1981) 0.84
Alpha-adrenoceptor blocking activity of fenoldopam (SK&F 82526), a selective DA1 agonist. J Pharm Pharmacol (1986) 0.83
Sulpiride: a weak antagonist of norepinephrine and 5-hydroxytryptamine. Eur J Pharmacol (1979) 0.81
Antagonism of prostanoid-induced vascular contraction by 13-azaprostanoic acid (13-APA). J Cardiovasc Pharmacol (1984) 0.81
N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist. J Pharmacol Exp Ther (1978) 0.80
Comparison of the cardiovascular actions of dopamine and epinine in the dog. J Pharmacol Exp Ther (1985) 0.80
Contractile actions of racemic and d-propranolol on isolated canine mesenteric and coronary arteries. J Pharmacol Exp Ther (1982) 0.78
Specific dopamine D-1 and DA1 properties of 4-(mono- and -dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline and its tetrahydrothieno[2,3-c]pyridine analogue. J Med Chem (1987) 0.78
Hypotensive effects of N,N-din-n-propylodopamine in the anesthetized dog: comparison with sodium nitroprusside. J Cardiovasc Pharmacol (1980) 0.78
Effects of dopamine, N-N-di-n-propyl dopamine, and (R)- and (S)-sulpiride on guinea pig blood pressure. J Cardiovasc Pharmacol (1982) 0.78
Conformational requirements for dopamine-induced vasodilation. Proc Natl Acad Sci U S A (1977) 0.77
Influence of anesthetics and of arterial blood pressure on the functional refractory period of atrioventricular conduction. J Pharmacol Exp Ther (1966) 0.77
Effects of ring fluorination on the cardiovascular actions of dopamine and norepinephrine in the dog. J Pharmacol Exp Ther (1980) 0.77
Pharmacological characterization of the postsynaptic alpha-adrenoceptors in isolated canine mesenteric arteries and veins. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.76
Vascular relaxing activity and stability studies of 10,10-difluoro-13,14-dehydroprostacyclin. Proc Natl Acad Sci U S A (1980) 0.75
Acute toxicity of Iomex--a petroleum weedicide. Bull Environ Contam Toxicol (1975) 0.75
Bulbocapnine is not a selective DA1 receptor antagonist. J Pharm Pharmacol (1986) 0.75
Influence of sex hormones on parathion toxicity in rats: antiacetylcholinesterase activity of parathion and paraoxon in plasma, erythrocytes, and brain. J Toxicol Environ Health (1982) 0.75
Dermal absorption of fenitrothion in rat. Bull Environ Contam Toxicol (1974) 0.75
Modification of cardiovascular actions of 2-amino-5,6-dihydroxytetralin by N,N-di-n-propyl substitution. Eur J Pharmacol (1982) 0.75
Catecholamine injections in canine paravertebral ganglia produce hypotension by neurogenic vasodilatation. Cardiologia (1990) 0.75
Interactions between different prostaglandins and other relaxing agents on isolated vascular smooth muscle. Adv Prostaglandin Thromboxane Res (1980) 0.75
Inhibitory effects of catecholamines in the paravertebral sympathetic ganglia of the anesthetized dog. Eur J Pharmacol (1990) 0.75
Absence of postsynaptic DA2 dopamine receptors in the dog renal vasculature. Eur J Pharmacol (1991) 0.75
Consistent unmasking of dopamine-induced dilation of the canine femoral vascular bed. J Pharmacol Exp Ther (1980) 0.75
Absorption and excretion of 2,4,5-trichlorophenoxy acetic acid in man. Arch Int Pharmacodyn Ther (1974) 0.75
Similarities and differences of dopamine receptors in the renal vascular bed and elsewhere. Adv Biochem Psychopharmacol (1977) 0.75
Differential antagonism of postsynaptic (DA1) and presynaptic (DA2) peripheral dopamine receptors by substituted benzamides. Adv Biochem Psychopharmacol (1982) 0.75
Conformational requirements for vascular alpha-adrenergic activity. Proc Soc Exp Biol Med (1978) 0.75
Potentiation by dopexamine of the cardiac responses to circulating and neuronally released norepinephrine: a possible mechanism for the therapeutic effects of the drug. J Cardiovasc Pharmacol (1989) 0.75
Vascular smooth muscle activity of 7-oxa-13-prostynoic acid. Blood Vessels (1979) 0.75
Effects of alpha adrenoceptor and dopamine receptor agonists and antagonists on ganglionic transmission. J Pharmacol Exp Ther (1989) 0.75
Effects of 3',4'-dihydroxynomifensine on the dopamine vascular receptor. J Pharm Pharmacol (1980) 0.75
Relative contracting and relaxing potencies of a series of prostaglandins on isolated canine mesenteric artery strips. Prostaglandins (1981) 0.75
Dopamine vascular actions of N-substituted derivatives of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN). Eur J Pharmacol (1979) 0.75
Studies on the functional role of alpha-adrenoceptors in the cardiac sympathetic ganglia of the dog. Life Sci (1992) 0.75
Identification and characterization of dopamine receptors in the cardiovascular system. Cardiologia (1987) 0.75
Interaction of sympathomimetic amines with alpha-receptors and 5-hydroxytryptamine receptors in rabbit aorta. Arch Int Pharmacodyn Ther (1970) 0.75
Effect of ring fluorination of epinephrine on its cardiovascular adrenoceptor activities. Eur J Pharmacol (1990) 0.75
Facilitation of ganglionic transmission by sulpiride: evidence for an inhibitory role of dopamine in the canine sympathetic ganglion. J Pharmacol Exp Ther (1982) 0.75
Stable carbocyclic analog of thromboxane A2 as antagonist of prostaglandin receptors. Adv Prostaglandin Thromboxane Leukot Res (1983) 0.75
Synthesis of 2-(alkylamino)-5,6- and -6,7-dihydroxy-3,4-dihydroquinazolines and evaluation as potential dopamine agonists. J Med Chem (1982) 0.75
C(2)-Methylation abolishes DA1 dopamine agonist activity of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (6,7-ADTN): steric intolerance by the receptor. J Med Chem (1984) 0.75
Studies on the location of catecholamine receptors in canine sympathetic ganglia. Eur J Pharmacol (1992) 0.75
Effects of the enantiomers of 3-PPP on DA1 and DA2 dopamine receptors in the dog. Eur J Pharmacol (1985) 0.75